The international Union Against Tuberculosis and Lung Diseases, Paris

Academic/Hospital

Also known as: International Union Against Tuberculosis and Lung Diseases | The international Union Against Tuberculosis and Lung Diseases (IUATLD), Paris, France

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2009

Last known activity

Oct 7, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 3 trials)

Phase 3 (3 own, 0 via acquisition)

linezolid
pretomanid
bedaquiline

Phase 2 (5 own, 0 via acquisition)

efavirenz
ritonavir
nevirapine
lopinavir
rifabutin

Indications

Studied for

Acquired Immunodeficiency Syndrome
Communicable Diseases
HIV Infections
Infections
Tuberculosis

Recent trials (3)

NCT05040126CollaboratorPhase 3Oct 7, 2021
NCT00651066Overall official - principal investigatorPhase 2Jun 1, 2010
NCT00640887Overall official - principal investigatorPhase 2Feb 1, 2009

Details

Last known activity: Oct 7, 2021